AdJane Unveils Mucosal Booster Strategy for Next-Generation Respiratory Vaccine Franchises
White Paper shows how AdJane’s clinically validated Nm-nOMV platform could add a proprietary mucosal component to existing intramuscular vaccination programs DELFT, The Netherlands, Sept. 10, 2026 /PRNewswire/ — AdJane Biosciences (“AdJane”), a
